Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer

Clinical trial NCT06624878 · COMPLETED

Trial details

NCT number: NCT06624878
Sponsor: Zhejiang Cancer Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Ovarian Cancer Cytoreductive Surgery Depressive Symptom

Start date: 2024-10-08
Primary completion: 2026-01-14
Enrollment: 568

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.